Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for tough prostate cancer: phase 3 trial launches

NCT ID NCT06136650

Disease control Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 8 times

Summary

This study tests a new drug called opevesostat (plus hormone replacement therapy) against two standard treatments (abiraterone or enzalutamide) in about 1,300 men with metastatic castration-resistant prostate cancer that got worse after one prior hormone therapy. The goal is to see if opevesostat can delay cancer growth or improve survival. Participants must have confirmed prostate cancer that has spread and is still progressing despite standard hormone treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 1,314 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2023

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: The main inclusion criteria include but are not limited to the following: * Have histologically or cytologically confirmed adenocarcinoma of the prostate without small cell histology * Has prostate cancer progression while receiving androgen deprivation therapy (ADT) (or post bilateral orchiectomy) within 6 months before screening * Has current evidence of distant metastatic disease (M1 disease) documented by either bone lesions on bone scan and/or soft tissue disease shown by computed tomography (CT)/magnetic resonance imaging (MRI) * Has disease that progressed during or after treatment with one next-generation hormonal agent (NHA) for hormone sensitive prostate cancer (HSPC) (metastatic hormone-sensitive prostate cancer \[mHSPC\] or non-metastatic hormone-sensitive prostate cancer \[nmHSPC\]), or castration-resistant prostate cancer (CRPC) (metastatic castration-resistant prostate cancer \[mCRPC\] or non-metastatic castration-resistant prostate cancer \[nmCRPC\]), for at least 8 weeks of NHA treatment (at least 14 weeks of NHA treatment for participants with bone progression). Note: Participants may have received abiraterone acetate and docetaxel or darolutamide and docetaxel for HSPC. However, participants must have received no more than 6 cycles of docetaxel and had no radiographic disease progression while receiving docetaxel * Has had prior treatment with poly (ADP-ribose) polymerase inhibitor (PARPi) or were deemed ineligible to receive treatment by the investigator or have refused PARPi treatment * Has ongoing androgen deprivation therapy (ADT) with serum testosterone \<50 ng/dL (\<1.7 nM) * Has an eastern clinical oncology group (ECOG) performance status of 0 or 1 assessed within 10 days before randomization * Has adequate organ function * Has provided tumor tissue from a fresh core or excisional biopsy from soft tissue not previously irradiated. Samples from tumors progressing at a prior site of radiation are allowed * Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at least 4 weeks and have undetectable HBV viral load before randomization * Participants with history of hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable at screening * Participants who have adverse event (AEs) due to previous anticancer therapies must have recovered to ≤Grade 1 or baseline. Participants with endocrine-related AEs who are adequately treated with hormone replacement or participants who have ≤Grade 2 neuropathy or ≤Grade 2 osteopenia/osteoporosis are eligible * Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on antiretroviral therapy (ART) Exclusion Criteria: The main exclusion criteria include but are not limited to the following: * Has presence of gastrointestinal condition * Is unable to swallow capsules/tablets * Has history of pituitary dysfunction * Has poorly controlled diabetes mellitus * Has clinically significant abnormal serum potassium or sodium level * Has any of the following at screening visit: Hypotension: systolic blood pressure (BP) \<110 mmHg, or uncontrolled hypertension: systolic BP ≥160mmHg or diastolic blood BP ≥90 mmHg, in 2 out of the 3 recordings with optimized antihypertensive therapy * Has a history of active or unstable cardio/cerebrovascular disease, including thromboembolic events * History or family history of long QTc syndrome * Has a history of seizure(s) within 6 months before providing documented informed consent (IC) or has any condition that may predispose to seizure within 12 months prior to the date of enrollment * Has a history of clinically significant ventricular arrhythmias or Mobitz II second degree or third-degree heart block without a permanent pacemaker in place * Has received a taxane-based chemotherapy for metastatic castration-resistant prostate cancer (mCRPC) * Has not adequately recovered from major surgery or have ongoing surgical complications * Is currently being treated with Cytochrome P450 (CYP450)-inducing antiepileptic drugs for seizures * Participants on an unstable dose of thyroid hormone therapy, as judged by the investigator, within 6 months before the start of the study intervention * Receives prior radiotherapy within 2 weeks before the first dose of study intervention, or radiation-related toxicities, requiring corticosteroids * Receives prior systemic anticancer therapy including investigational agents within 4 weeks before the first dose of study intervention * Has systemic use of strong Cytochrome P450 3A4 (CYP3A4) inducers and P-glycoprotein (P-gp) inhibitors within 2 weeks before the first dose of study intervention * Has received prior targeted small molecule therapy or NHA treatment within 4 weeks before the first dose of study intervention * Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention * Has received an investigational agent or has used an investigational device within 4 weeks prior to study intervention administration * Has known hypersensitivity to the components or excipients in abiraterone acetate, prednisone or prednisolone, enzalutamide, fludrocortisone, dexamethasone, or opevesostat * Has a "superscan" bone scan defined as an intense symmetric activity in the bones and diminished renal parenchymal activity on baseline bone scan such that the presence of additional metastases in the future could not be evaluated * Has known additional malignancy that is progressing or has required active treatment within the past 3 years * Diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication * Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis. Participants with previously treated brain metastases may participate provided they are radiologically stable, (ie, without evidence of progression) for at least 4 weeks as confirmed by repeat imaging performed during study screening, are clinically stable and have not required steroid treatment for at least 14 days prior to the first dose of study intervention * Has active autoimmune disease that has required systemic treatment in the past 2 years. Replacement therapy is allowed * Active infection requiring systemic therapy * Has concurrent active Hepatitis B virus and Hepatitis C virus infection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metastatic castration resistant prostate cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

castration-resistant prostate carcinoma metastatic prostate carcinoma prostate cancer prostate neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metastatic castration-resistant prostate cancer (MCRPC) Prostatic neoplasms

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    298 sites in 39 countries. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • ATTIKON GENERAL UNIVERSITY HOSPITAL-2nd Dep. of Int. Medicine. Research Unit & Diabetes Center ( Site 0552)

    RECRUITING

    Chaïdári, Attica, 124 62, Greece

  • Ad-Vance Medical Research-Research ( Site 1177)

    RECRUITING

    Ponce, 00717, Puerto Rico

  • Addenbrooke's Hospital ( Site 1426)

    RECRUITING

    Cambridge, Cambridgeshire, CB2 2QQ, United Kingdom

  • Advance Urology and Laparoscopic Center ( Site 1178)

    COMPLETED

    Ponce, 00716, Puerto Rico

  • Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1301)

    RECRUITING

    Uppsala, Uppsala County, 751 85, Sweden

  • Akita University Hospital ( Site 0728)

    RECRUITING

    Akita, 010-8543, Japan

  • Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0551)

    RECRUITING

    Athens, Attica, 115 28, Greece

  • Aliada-Oncologìa ( Site 1055)

    RECRUITING

    Lima, 15036, Peru

  • Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1377)

    RECRUITING

    Ankara, 06800, Turkey (Türkiye)

  • Associated Medical Professionals - Urology ( Site 0081)

    RECRUITING

    Syracuse, New York, 13210, United States

  • Auckland City Hospital ( Site 1033)

    RECRUITING

    Auckland, 1023, New Zealand

  • Avera Cancer Institute - Aberdeen ( Site 0123)

    RECRUITING

    Aberdeen, South Dakota, 57401, United States

  • Avera Cancer Institute - Marshall ( Site 0122)

    RECRUITING

    Marshall, Minnesota, 56258, United States

  • Avera Cancer Institute - Mitchell ( Site 0121)

    RECRUITING

    Mitchell, South Dakota, 57301, United States

  • Avera Cancer Institute - Pierre ( Site 0118)

    RECRUITING

    Pierre, South Dakota, 57501, United States

  • Avera Cancer Institute - Yankton ( Site 0117)

    RECRUITING

    Yankton, South Dakota, 57078, United States

  • Avera Cancer Institute- Research ( Site 0094)

    RECRUITING

    Sioux Falls, South Dakota, 57105, United States

  • Azienda Ospedaliera Santa Maria Terni ( Site 1458)

    RECRUITING

    Terni, 05100, Italy

  • Azienda Ospedaliero Universitaria Policlinico Riuniti di Foggia ( Site 1456)

    RECRUITING

    Foggia, 71100, Italy

  • BC Cancer Abbotsford-Clinical Trials Unit ( Site 0287)

    RECRUITING

    Abbotsford British Columbia, British Columbia, V2S 0C2, Canada

  • Baltimore Veterans Affairs Medical Center ( Site 0069)

    RECRUITING

    Baltimore, Maryland, 21201, United States

  • Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1379)

    RECRUITING

    Adana, 01250, Turkey (Türkiye)

  • Beijing Cancer Hospital ( Site 1623)

    RECRUITING

    Beijing, Beijing Municipality, 130021, China

  • Beijing Cancer hospital-Urinary Surgery ( Site 1620)

    RECRUITING

    Beijing, Beijing Municipality, 100142, China

  • Bell Land General Hospital ( Site 0740)

    RECRUITING

    Sakai, Osaka, 599-8247, Japan

  • Blue Ridge Cancer Care ( Site 0004)

    RECRUITING

    Roanoke, Virginia, 24014, United States

  • Borsod-Abaúj-Zemplén Megyei Központi Kórház és Egyetemi Okta-Klinikai Onkológiai és Sugárterápiás C ( Site 0630)

    RECRUITING

    Miskolc, Borsod-Abauj Zemplen county, 3526, Hungary

  • Bradfordhill-Clinical Area ( Site 0301)

    RECRUITING

    Santiago, Region M. de Santiago, 8420383, Chile

  • CANCERCARE LANGENHOVEN DRIVE ONCOLOGY CENTRE-Clinical Trials Unit ( Site 1230)

    RECRUITING

    Port Elizabeth, Eastern Cape, 6055, South Africa

  • CELAN,S.A ( Site 0579)

    RECRUITING

    Guatemala City, 01010, Guatemala

  • CENTRE LEON BERARD ( Site 0459)

    RECRUITING

    Lyon Cedex08, Auvergne-Rhône-Alpes, 69373, France

  • CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120)

    RECRUITING

    Irvine, California, 92612, United States

  • CHU-BREST Cavale Blanche ( Site 0456)

    RECRUITING

    Brest, Finistere, 29200, France

  • CIDO SpA-Oncology ( Site 0302)

    RECRUITING

    Temuco, Araucania, 4810218, Chile

  • CIMCA-Hemato-Oncology ( Site 0380)

    RECRUITING

    San José, Provincia de San José, 10103, Costa Rica

  • CIO - Centro de Inmuno-Oncología de Occidente ( Site 0928)

    RECRUITING

    Guadalajara, Jalisco, 44630, Mexico

  • CRIO - CENTRO REGIONAL INTEGRADO DE ONCOLOGIA ( Site 0256)

    RECRUITING

    Fortaleza, Ceará, 60336-232, Brazil

  • Cancer Clinics of North Texas ( Site 0077)

    COMPLETED

    Dallas, Texas, 75243, United States

  • Cancer and Hematology Centers of Western Michigan ( Site 0005)

    RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Cape Town Oncology Trials ( Site 1233)

    COMPLETED

    Cape Town, Western Cape, 7570, South Africa

  • Cardiomed SRL Cluj-Napoca ( Site 1503)

    COMPLETED

    Cluj-Napoca, Cluj, 400015, Romania

  • Caritas-Krankenhaus St. Josef-Klinik fuer Urologie ( Site 0523)

    RECRUITING

    Regensburg, Bavaria, 93053, Germany

  • Central Ohio Urology Group - Gahanna ( Site 0098)

    COMPLETED

    Gahanna, Ohio, 43230, United States

  • Centre Bourgogne ( Site 0464)

    RECRUITING

    Lille, Hauts-de-France, 59000, France

  • Centre Hospitalier de l'Université de Montréal ( Site 0276)

    RECRUITING

    Montreal, Quebec, H2X 3E4, Canada

  • Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 0454)

    RECRUITING

    Clermont-Ferrand, Puy-de-Dome, 63003, France

  • Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0277)

    RECRUITING

    Québec, Quebec, G1J 1Z4, Canada

  • Centro de Investigacion Clinica de Oaxaca ( Site 0934)

    RECRUITING

    Mexico City, Mexico City, 68020, Mexico

  • Centrul de Oncologie "Sfântul Nectarie" ( Site 1501)

    RECRUITING

    Craiova, Dolj, 200746, Romania

  • Chang Gung Medical Foundation-Linkou Branch-Urology ( Site 1334)

    RECRUITING

    Taoyuan, 333, Taiwan

  • Chang Gung Memorial Hospital at Kaohsiung-Oncology and Hematology ( Site 1331)

    RECRUITING

    Kaohsiung City, 83301, Taiwan

  • Charing Cross Hospital ( Site 1434)

    RECRUITING

    London, London, City of, W6 8RF, United Kingdom

  • Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0504)

    RECRUITING

    Berlin, 10117, Germany

  • Chesapeake Urology ( Site 0009)

    RECRUITING

    Towson, Maryland, 21204, United States

  • Chi Mei Medical Center ( Site 1336)

    RECRUITING

    Tainan, Tainan, 71004, Taiwan

  • China Medical University Hospital-Department of Urology ( Site 1335)

    RECRUITING

    Taichung, 40447, Taiwan

  • Chongqing University Cancer Hospital ( Site 1603)

    RECRUITING

    Chongqing, Chongqing Municipality, 400030, China

  • Chulalongkorn University ( Site 1355)

    RECRUITING

    Pathumwan, Bangkok, 10330, Thailand

  • Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0326)

    RECRUITING

    Bogotá, Bogota D.C., 111321, Colombia

  • Clinica Universidad Catolica del Maule-Oncology ( Site 0306)

    RECRUITING

    Talca, Maule Region, 3465584, Chile

  • Clínica Imbanaco S.A.S ( Site 0334)

    RECRUITING

    Cali, Valle del Cauca Department, 760042, Colombia

  • Clínica de Neoplasias Litoral ( Site 0269)

    RECRUITING

    Itajaí, Santa Catarina, 88301-220, Brazil

  • Colorado Clinical Research ( Site 0067)

    RECRUITING

    Lakewood, Colorado, 80228, United States

  • Complexo Hospitalario Universitario A Coruna ( Site 1288)

    RECRUITING

    A Coruña, La Coruna, 15006, Spain

  • Comprehensive Cancer Centers of Nevada ( Site 0010)

    RECRUITING

    Las Vegas, Nevada, 89148, United States

  • Cross Cancer Institute ( Site 0281)

    RECRUITING

    Edmonton, Alberta, T6G 1Z2, Canada

  • Curo Oncology. ( Site 1237)

    RECRUITING

    Pretoria, Gauteng, 0084, South Africa

  • Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 0632)

    RECRUITING

    Debrecen, 4032, Hungary

  • Delta Health Care SRL ( Site 1507)

    RECRUITING

    Bucharest, 014142, Romania

  • Dunedin Hospital ( Site 1032)

    COMPLETED

    Dunedin, Otago, 9016, New Zealand

  • East-Tallinn Central Hospital ( Site 1528)

    RECRUITING

    Tallinn, Harju, 11314, Estonia

  • Edward-Elmhurst Healthcare, Edward Hospital-Edward Cancer Center ( Site 0075)

    COMPLETED

    Naperville, Illinois, 60540, United States

  • Edward-Elmhurst Healthcare, Elmhurst Hospital-Nancy W. Knowles Cancer Center ( Site 0074)

    COMPLETED

    Elmhurst, Illinois, 60126, United States

  • Ege Universitesi Hastanesi-Medical Oncology ( Site 1380)

    RECRUITING

    Izmir, 35100, Turkey (Türkiye)

  • Emad Ibrahim,MD,INC. ( Site 0012)

    COMPLETED

    Redlands, California, 92373, United States

  • Emek Medical Center ( Site 0680)

    RECRUITING

    Afula, 1834111, Israel

  • Eukarya Pharmasite S.C. ( Site 0939)

    RECRUITING

    Monterrey, Nuevo León, 64718, Mexico

  • FALP ( Site 0303)

    RECRUITING

    Santiago, Region M. de Santiago, 7500921, Chile

  • Faculty of Medicine - Khon Kaen University ( Site 1351)

    RECRUITING

    Muang, Changwat Khon Kaen, 40002, Thailand

  • Faculty of Medicine Siriraj Hospital ( Site 1356)

    RECRUITING

    Bangkoknoi, Bangkok, 10700, Thailand

  • Fakultni Nemocnice u sv. Anny v Brne-Onkologicko-chirurgicke oddeleni ( Site 0404)

    RECRUITING

    Brno, South Moravian, 602 00, Czechia

  • Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0405)

    RECRUITING

    Olomouc, 77900, Czechia

  • Fakultni nemocnice v Motole-Onkologicka klinika 2. LF UK a FN Motol ( Site 0401)

    RECRUITING

    Prague, Praha 5, 150 06, Czechia

  • Filios Alta Medicina ( Site 0931)

    RECRUITING

    Monterrey, Nuevo León, 64460, Mexico

  • First Medical Center of Chinese PLA General Hospital ( Site 1601)

    RECRUITING

    Beijing, Beijing Municipality, 100853, China

  • Florida Cancer Specialists - South ( Site 7003)

    RECRUITING

    Fort Myers, Florida, 33901, United States

  • Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1452)

    RECRUITING

    Milan, Lombardy, 20133, Italy

  • Fox Chase Cancer Center ( Site 0076)

    RECRUITING

    Philadelphia, Pennsylvania, 19111, United States

  • Fukushima Medical University Hospital ( Site 0758)

    RECRUITING

    Fukushima, 960-1295, Japan

  • Fundación Cardiovascular de Colombia ( Site 0328)

    RECRUITING

    Piedecuesta, Santander Department, 681017, Colombia

  • Fundación Valle del Lili ( Site 0330)

    RECRUITING

    Cali, Valle del Cauca Department, 760032, Colombia

  • Genesis Healthcare System ( Site 0102)

    COMPLETED

    Zanesville, Ohio, 43701, United States

  • GenesisCare - Oxford ( Site 1442)

    RECRUITING

    Oxford, Oxfordshire, OX4 6LB, United Kingdom

  • GenesisCare - Windsor ( Site 1443)

    RECRUITING

    Windsor, Windsor And Maidenhead, SL4 3HD, United Kingdom

  • Gifu University Hospital ( Site 0736)

    RECRUITING

    Gifu, 501-1112, Japan

  • Greenebaum Comprehensive Cancer Center ( Site 0049)

    RECRUITING

    Baltimore, Maryland, 21201, United States

  • Groupe Hospitalier Paris Saint Joseph ( Site 0465)

    RECRUITING

    Paris, 75014, France

  • Gustave Roussy ( Site 0452)

    RECRUITING

    Villejuif, Val-de-Marne, 94800, France

  • Guy's & St Thomas' NHS Foundation Trust-Oncology & Haematology Clinical Trials ( Site 1435)

    RECRUITING

    London, London, City of, SE1 9RT, United Kingdom

  • HOSPITAL CLÍNIC DE BARCELONA-ICHMO- Clinic Institut of Haematological and Oncological diseases ( Site 1284)

    RECRUITING

    Barcelona, Catalonia, 08036, Spain

  • HOSPITAL UNIVERSITARIO QUIRONSALUD MADRID-ONCOLOGIA MEDICA ( Site 1283)

    RECRUITING

    Pozuelo de Alarcón, Madrid, 28223, Spain

  • Hacettepe Universite Hastaneleri-oncology hospital ( Site 1376)

    RECRUITING

    Ankara, 06230, Turkey (Türkiye)

  • Hadassah Medical Center ( Site 0683)

    RECRUITING

    Jerusalem, 9112001, Israel

  • Health Pharma Professional Research S.A. de C.V: ( Site 0929)

    RECRUITING

    Mexico City, Mexico City, 03100, Mexico

  • HealthPartners Cancer Research Center-HealthPartners Cancer Center at Regions Hospital ( Site 0092)

    RECRUITING

    Saint Paul, Minnesota, 55101, United States

  • HealthPartners Cancer Research Center-HealthPartners Frauenshuh Cancer Center ( Site 0072)

    RECRUITING

    Saint Louis Park, Minnesota, 55426, United States

  • Henry Ford Hospital ( Site 0015)

    RECRUITING

    Detroit, Michigan, 48202, United States

  • Higiea Oncologia ( Site 0938)

    RECRUITING

    Mexico City, Mexico City, 11810, Mexico

  • Hiroshima University Hospital ( Site 0743)

    COMPLETED

    Hiroshima, 734-8551, Japan

  • Hokkaido University Hospital ( Site 0756)

    RECRUITING

    Sapporo, Hokkaido, 060-8648, Japan

  • Hong Kong Integrated Oncology Centre ( Site 0603)

    RECRUITING

    Central, 999077, Hong Kong

  • Hopitaux Universitaires de Strasbourg- Hopital de Hautepierre ( Site 0451)

    RECRUITING

    Strasbourg, Bas-Rhin, 67200, France

  • Hospital CUF - Tejo ( Site 1157)

    RECRUITING

    Lisbon, 1350-352, Portugal

  • Hospital Insular de Gran Canaria-Oncology ( Site 1280)

    RECRUITING

    Las Palmas de Gran Canaria, Las Palmas, 35016, Spain

  • Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 0903)

    RECRUITING

    Kuala Lumpur, 50586, Malaysia

  • Hospital Mario Penna ( Site 0264)

    RECRUITING

    Belo Horizonte, Minas Gerais, 30380-472, Brazil

  • Hospital Metropolitano - Sede Lindora-Metropolitano Research Institute Sede Lindora ( Site 0379)

    RECRUITING

    Santa Ana, Provincia de San José, 10903, Costa Rica

  • Hospital Paulistano ( Site 0259)

    RECRUITING

    São Paulo, 01321-001, Brazil

  • Hospital Quirón Málaga ( Site 1286)

    RECRUITING

    Málaga, 29004, Spain

  • Hospital Santa Rita de Cassia ( Site 0271)

    RECRUITING

    Vitória, Espírito Santo, 29043-260, Brazil

  • Hospital Sultan Ismail ( Site 0905)

    RECRUITING

    Johor Bahru, Johor, 81100, Malaysia

  • Hospital São Domingos ( Site 0258)

    RECRUITING

    São Luís, Maranhão, 65060-645, Brazil

  • Hospital São Lucas da PUCRS ( Site 0270)

    RECRUITING

    Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

  • Hospital Universitari Parc Tauli-oncologia ( Site 1282)

    RECRUITING

    Sabadell, Barcelona, 08208, Spain

  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 0932)

    RECRUITING

    Monterrey, Nuevo León, 64460, Mexico

  • Hospital Universitario de Burgos-Oncología ( Site 1281)

    RECRUITING

    Burgos, 09006, Spain

  • Hospital Universitário Evangélico Mackenzie ( Site 0252)

    RECRUITING

    Curitiba, Paraná, 80730-150, Brazil

  • Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0251)

    RECRUITING

    Bragança Paulista, São Paulo, 12916-542, Brazil

  • Hospital de Base de São José do Rio Preto ( Site 0275)

    RECRUITING

    São José do Rio Preto, São Paulo, 15090-000, Brazil

  • Hospital de Cascais Doutor José de Almeida ( Site 1158)

    RECRUITING

    Alcabideche, Lisbon District, 2755-009, Portugal

  • Hospital of Lithuanian University of Health Sciences Kauno klinikos ( Site 1576)

    RECRUITING

    Kaunas, Kaunas County, 50161, Lithuania

  • Hospital of the University of Occupational and Environmental Health, Japan ( Site 0746)

    RECRUITING

    Kitakyushu, Fukuoka, 807-8556, Japan

  • Huadong Hospital Affiliated to Fudan University-Urology ( Site 1613)

    RECRUITING

    Shanghai, Shanghai Municipality, 200041, China

  • Hubei Cancer Hospital-Urinary surgery ( Site 1631)

    RECRUITING

    Wuhan, Hubei, 430079, China

  • Hunan Cancer Hospital ( Site 1630)

    RECRUITING

    Changsha, Hunan, 410013, China

  • Hôpital Foch ( Site 0455)

    RECRUITING

    Suresnes, Hauts-de-Seine, 92150, France

  • ICTRIALS Pesquisa e Desenvolvimento ( Site 0274)

    RECRUITING

    Curitiba, Paraná, 80510-130, Brazil

  • IMAT S.A.S ( Site 0329)

    RECRUITING

    Montería, Departamento de Córdoba, 230002, Colombia

  • INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1054)

    ACTIVE_NOT_RECRUITING

    Lima, 15038, Peru

  • INTEGRA Cancer Institute-Oncology ( Site 0578)

    RECRUITING

    Guatemala City, 01010, Guatemala

  • IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1052)

    RECRUITING

    Lima, 15036, Peru

  • IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 1454)

    RECRUITING

    Meldola, Emilia-Romagna, 47014, Italy

  • Illinois Cancer Care ( Site 0104)

    RECRUITING

    Peoria, Illinois, 61615, United States

  • Inova Schar Cancer Institute ( Site 0017)

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest ( Site 0461)

    RECRUITING

    Bordeaux, Aquitaine, 33076, France

  • Institut Català d'Oncologia (ICO) - Girona ( Site 1285)

    RECRUITING

    Girona, Gerona, 17007, Spain

  • Instituto do Câncer Brasil - Unidade Taubaté ( Site 0263)

    RECRUITING

    Taubaté, São Paulo, 12030-200, Brazil

  • Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1383)

    RECRUITING

    Istanbul, 34668, Turkey (Türkiye)

  • Kagawa University Hospital ( Site 0744)

    RECRUITING

    Kita, Kagawa-ken, 761-0701, Japan

  • Kagoshima University Hospital ( Site 0754)

    COMPLETED

    Kagoshima, 890-8520, Japan

  • Kaiser Permanente Riverside Medical Center ( Site 0099)

    RECRUITING

    Riverside, California, 92505, United States

  • Kaiser Permanente-Kaiser Permanente, Vallejo Medical Center, Adult Oncology ( Site 0101)

    ACTIVE_NOT_RECRUITING

    Vallejo, California, 94589, United States

  • Kanazawa Medical University Hospital ( Site 0734)

    RECRUITING

    Mukai-awagasaki, Ishikawa-ken, 920-0265, Japan

  • Kansai Medical University Hospital ( Site 0739)

    RECRUITING

    Hirakata, Osaka, 573-1191, Japan

  • Kaohsiung Veterans General Hospital ( Site 1337)

    RECRUITING

    Kaohsiung City, 81362, Taiwan

  • Karolinska Universitetssjukhuset Solna ( Site 1302)

    RECRUITING

    Stockholm, Stockholm County, 171 64, Sweden

  • Kobe University Hospital ( Site 0741)

    RECRUITING

    Kobe, Hyōgo, 650-0017, Japan

  • Koc Universitesi Hastanesi ( Site 1384)

    RECRUITING

    Istanbul, 34010, Turkey (Türkiye)

  • Krajská nemocnice Liberec-Department of Urology ( Site 0407)

    COMPLETED

    Liberec, Liberec Region, 460 01, Czechia

  • Kyungpook National University Chilgok Hospital-Urology ( Site 1252)

    RECRUITING

    Buk-gu, Kyongsangbuk-do, 41404, South Korea

  • Kyushu University Hospital ( Site 0745)

    RECRUITING

    Fukuoka, 812-8582, Japan

  • LIFE GROENKLOOF-Mary Potter Cancer Centre ( Site 1236)

    RECRUITING

    Pretoria, Gauteng, 0181, South Africa

  • Liepaja Regional Hospital ( Site 1553)

    ACTIVE_NOT_RECRUITING

    Liepāja, LV3414, Latvia

  • Los Cobos Medical Center ( Site 0336)

    COMPLETED

    Bogotá, Bogota D.C., 110121, Colombia

  • MEDI-K ( Site 0576)

    RECRUITING

    Guatemala City, 01009, Guatemala

  • Macquarie University-MQ Health Clinical Trials Unit ( Site 0214)

    RECRUITING

    Macquarie University, New South Wales, 2109, Australia

  • Maharaj Nakorn Chiang Mai Hospital ( Site 1353)

    RECRUITING

    Muang, Chiang Mai, 50200, Thailand

  • Marien-Krankenhaus ( Site 0515)

    RECRUITING

    Bergisch Gladbach, North Rhine-Westphalia, 51465, Germany

  • Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0403)

    RECRUITING

    Brno, Brno-mesto, 656 53, Czechia

  • MedStar Washington Hospital Center ( Site 0103)

    RECRUITING

    Washington D.C., District of Columbia, 20010, United States

  • Medical College of Wisconsin ( Site 0020)

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Meir Medical Center. ( Site 0682)

    RECRUITING

    Kfar Saba, 4428164, Israel

  • Memorial Hospital West-Memorial Cancer Institute ( Site 0109)

    RECRUITING

    Pembroke Pines, Florida, 33028, United States

  • MidLantic urology ( Site 0022)

    RECRUITING

    Bala-Cynwyd, Pennsylvania, 19004, United States

  • Mie University Hospital ( Site 0737)

    RECRUITING

    Tsu, Mie-ken, 514-8507, Japan

  • Miyazaki Prefectural Miyazaki Hospital ( Site 0752)

    RECRUITING

    Miyazaki, 880-8510, Japan

  • Monash Health ( Site 0219)

    RECRUITING

    Clayton, Victoria, 3168, Australia

  • Mount Sinai Braman Comprehensive Cancer Center ( Site 0107)

    RECRUITING

    Miami Beach, Florida, 33140, United States

  • Mount Vernon Cancer Centre ( Site 1440)

    RECRUITING

    Northwood, England, HA6 2RN, United Kingdom

  • Nagano Municipal Hospital ( Site 0757)

    RECRUITING

    Nagano, 381-8551, Japan

  • Nanbu Tokushukai Hospital ( Site 0755)

    RECRUITING

    Shimajiri, Okinawa, 901-0417, Japan

  • Nanchong Central Hospital-urology ( Site 1647)

    RECRUITING

    Nanchong, Sichuan, 500643, China

  • Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 1615)

    RECRUITING

    Nanjing, Jiangsu, 210008, China

  • Nantong Tumor Hospital-Urology ( Site 1609)

    RECRUITING

    Nantong, Jiangsu, 226361, China

  • Nara Medical University Hospital ( Site 0742)

    RECRUITING

    Kashihara, Nara, 634-8522, Japan

  • National Cancer Center-Center for Urologic Cancer ( Site 1254)

    RECRUITING

    Goyang-si, Kyonggi-do, 10408, South Korea

  • National Cancer Centre Singapore ( Site 1202)

    RECRUITING

    Singapore, Central Singapore, 168583, Singapore

  • National Cancer Institute ( Site 0904)

    COMPLETED

    Putrajaya, Putrajaya, 62250, Malaysia

  • National Hospital Organization Kumamoto Medical Center ( Site 0749)

    RECRUITING

    Kumamoto, 860-0008, Japan

  • National Hospital Organization Nagasaki Medical Center ( Site 0748)

    RECRUITING

    Ōmura, Nagasaki, 856-8562, Japan

  • National Hospital Organization Oita Medical Center ( Site 0750)

    COMPLETED

    Ōita, 870-0263, Japan

  • National University Hospital ( Site 1201)

    RECRUITING

    Singapore, Central Singapore, 119074, Singapore

  • Nihon University Itabashi Hospital ( Site 0732)

    COMPLETED

    Itabashiku, Tokyo, 173-8610, Japan

  • Ningbo First Hospital-Urology ( Site 1608)

    RECRUITING

    Ningbo, Zhejiang, 315010, China

  • Nograd Varmegyei Szent Lazar Korhaz-Onkologia es Sugarterapias Osztaly ( Site 0636)

    RECRUITING

    Salgótarján, Nógrád megye, 3100, Hungary

  • North Estonia Medical Centre Foundation ( Site 1526)

    RECRUITING

    Tallinn, Harju, 13419, Estonia

  • Northside Hospital-Northside Hospital Oncology Network ( Site 0100)

    ACTIVE_NOT_RECRUITING

    Atlanta, Georgia, 30342, United States

  • Northwest Cancer Specialists (Compass Oncology) ( Site 8008)

    ACTIVE_NOT_RECRUITING

    Vancouver, Washington, 98684, United States

  • ONCOCENTRO APYS-ACEREY ( Site 0305)

    RECRUITING

    Viña del Mar, Valparaiso, 2520598, Chile

  • Obras Sociais Irma Dulce ( Site 0255)

    RECRUITING

    Salvador, Estado de Bahia, 41680-430, Brazil

  • Onco Tech, S.A. ( Site 0376)

    RECRUITING

    San José, 10103, Costa Rica

  • Oncology Hematology West P.C. dba Nebraska Cancer Specialists ( Site 0026)

    RECRUITING

    Omaha, Nebraska, 68130, United States

  • Oncosalud-Clinical Research ( Site 1057)

    RECRUITING

    Lima, 15036, Peru

  • OptumCare Cancer Care-Research Department ( Site 0078)

    RECRUITING

    Las Vegas, Nevada, 89102, United States

  • Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 0631)

    RECRUITING

    Budapest, Pest County, 1122, Hungary

  • Ospedale Cannizzaro ( Site 1455)

    RECRUITING

    Catania, 95126, Italy

  • Ospedale San Raffaele-Oncologia Medica ( Site 1451)

    RECRUITING

    Milan, 20132, Italy

  • Pan American Center for Oncology Trials - Ciudadela ( Site 1176)

    RECRUITING

    San Juan, 00909, Puerto Rico

  • Pauls Stradins Clinical Univeristy Hospital-Urological department ( Site 1551)

    RECRUITING

    Riga, 1002, Latvia

  • Peking University First Hospital-Urology ( Site 1602)

    RECRUITING

    Beijing, Beijing Municipality, 100034, China

  • Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0210)

    RECRUITING

    Melbourne, Victoria, 3000, Australia

  • Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0304)

    RECRUITING

    Santiago, Region M. de Santiago, 8330024, Chile

  • Private Practice- Dr. Rixci Augusto Lenin Ramírez ( Site 0577)

    RECRUITING

    Guatemala City, 01010, Guatemala

  • Privatna Urologicka Ambulancia ( Site 1478)

    RECRUITING

    Trenčín, Trenčín Region, 911 01, Slovakia

  • Pusan National University Yangsan Hospital ( Site 1256)

    RECRUITING

    Pusan, Kyongsangnam-do, 50612, South Korea

  • Pärnu Haigla ( Site 1550)

    RECRUITING

    Pärnu, Pärnumaa, 80010, Estonia

  • Queen Mary Hospital ( Site 0602)

    RECRUITING

    Hong Kong, Hong Kong

  • Quemex Medical and Research ( Site 0937)

    RECRUITING

    Tlalpan, Mexico City, 14308, Mexico

  • Rabin Medical Center ( Site 0678)

    RECRUITING

    Petah Tikva, 4941492, Israel

  • Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083)

    RECRUITING

    Charleston, South Carolina, 29401, United States

  • Rambam Health Care Campus-Oncology Division ( Site 0676)

    RECRUITING

    Haifa, 3109601, Israel

  • Ramsay Santé - Clinical La Croix Du Sud ( Site 0460)

    COMPLETED

    Quint-Fonsegrives, Haute-Garonne, 31130, France

  • Renji Hosp Shanghai Jiaotong U School of Med ( Site 1624)

    RECRUITING

    Shanghai, Shanghai Municipality, 200001, China

  • Royal Brisbane and Women's Hospital-Medical Oncology Clinical Trials Unit, Cancer Care Services ( Site 0211)

    RECRUITING

    Brisbane, Queensland, 4029, Australia

  • Royal Derby Hospital ( Site 1431)

    RECRUITING

    Derby, Derbyshire, DE22 3NE, United Kingdom

  • Rutgers Cancer Institute of New Jersey ( Site 0033)

    RECRUITING

    New Brunswick, New Jersey, 08903, United States

  • SC Radiotherapy Center Cluj SRL ( Site 1502)

    COMPLETED

    Florești, Cluj, 407280, Romania

  • Saga-Ken Medical Centre Koseikan ( Site 0747)

    RECRUITING

    Saga, Saga-ken, 840-8571, Japan

  • Sainte Catherine Institut du Cancer Avignon Provence ( Site 0458)

    COMPLETED

    Avignon, Vaucluse, 84000, France

  • Samsun Medical Park Hastanesi-medical oncology ( Site 1382)

    RECRUITING

    Samsun, 55200, Turkey (Türkiye)

  • San Francisco VA Health Care System ( Site 0093)

    RECRUITING

    San Francisco, California, 94121, United States

  • Sanatorio Nuestra Senora del Pilar ( Site 0580)

    RECRUITING

    Guatemala City, 01015, Guatemala

  • Sapporo Medical University Hospital ( Site 0726)

    RECRUITING

    Sapporo, Hokkaido, 060-8543, Japan

  • Sarawak General Hospital-Radiotherapy Unit ( Site 0901)

    RECRUITING

    Kuching, Sarawak, 93586, Malaysia

  • Seoul National University Bundang Hospital-Urology ( Site 1253)

    RECRUITING

    Seongnam, Kyonggi-do, 13620, South Korea

  • Seoul National University Hospital-Urology ( Site 1251)

    RECRUITING

    Seoul, 03080, South Korea

  • Shaare Zedek Medical Center ( Site 0679)

    RECRUITING

    Jerusalem, 9103102, Israel

  • Sheba Medical Center ( Site 0677)

    RECRUITING

    Ramat Gan, 5265601, Israel

  • Singapore General Hospital ( Site 1204)

    RECRUITING

    Singapore, Central Singapore, 169608, Singapore

  • Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0327)

    RECRUITING

    Valledupar, Cesar Department, 200001, Colombia

  • Songklanagarind hospital ( Site 1352)

    RECRUITING

    Hat Yai, Changwat Songkhla, 90110, Thailand

  • Sourasky Medical Center ( Site 0681)

    RECRUITING

    Tel Aviv, 6423906, Israel

  • Southwest Hospital of Third Military Medical University ( Site 1645)

    RECRUITING

    Chongqing, Chongqing Municipality, 400038, China

  • Spitalul Clinic ''Prof Dr. Theodor Burghele'' ( Site 1505)

    RECRUITING

    Bucharest, 050659, Romania

  • Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu ( Site 1504)

    RECRUITING

    Bucharest, 11461, Romania

  • Spokane Urology ( Site 0035)

    RECRUITING

    Spokane, Washington, 99202, United States

  • St. George's Hospital-Oncology ( Site 1441)

    COMPLETED

    London, London, City of, SW17 0QT, United Kingdom

  • St. Vincent Frontier Cancer Center-Research ( Site 0037)

    RECRUITING

    Billings, Montana, 59102, United States

  • St. Vincent's University Hospital ( Site 0652)

    RECRUITING

    Dublin, Dublin, D04 T6F4, Ireland

  • Stanford Cancer Center ( Site 0036)

    RECRUITING

    Palo Alto, California, 94304, United States

  • Studienpraxis Urologie ( Site 0529)

    RECRUITING

    Nürtingen, Baden-Wurttemberg, 72622, Germany

  • Sun Yat-sen University Cancer Center-Urology Surgery ( Site 1638)

    RECRUITING

    Guangzhou, Guangdong, 510700, China

  • Sunnybrook Research Institute ( Site 0285)

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

  • T.C. Saglik Bakanligi Turkiye Kamu Hastaneleri Kurumu - Baki-Istanbul Bakirkoy Sadi Konuk Training ( Site 1381)

    RECRUITING

    Istanbul, 34147, Turkey (Türkiye)

  • TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1378)

    RECRUITING

    Istanbul, 34722, Turkey (Türkiye)

  • Taichung Veterans General Hospital ( Site 1338)

    RECRUITING

    Taichung, 40705, Taiwan

  • Taipei Veterans General Hospital ( Site 1332)

    RECRUITING

    Taipei, 112, Taiwan

  • Tallaght University Hospital ( Site 0651)

    RECRUITING

    Dublin, D24 NR0A, Ireland

  • Tan Tock Seng Hospital-Medical Oncology ( Site 1203)

    RECRUITING

    Singapore, Central Singapore, 308433, Singapore

  • Tartu University Hospital-Radiotherapy and oncology ( Site 1527)

    RECRUITING

    Tartu, Tartu, 50406, Estonia

  • Texas Oncology - Central/South Texas ( Site 8003)

    RECRUITING

    Austin, Texas, 78731, United States

  • Texas Oncology - DFW ( Site 8001)

    RECRUITING

    Dallas, Texas, 75246, United States

  • Texas Oncology - Gulf Coast ( Site 8002)

    RECRUITING

    Houston, Texas, 77024, United States

  • The Beatson West of Scotland Cancer Centre ( Site 1428)

    RECRUITING

    Glasgow, Glasgow City, G12 0YN, United Kingdom

  • The Catholic University of Korea. Seoul St. Mary s Hospital ( Site 1255)

    RECRUITING

    Seoul, 06591, South Korea

  • The Central Hospital of Wuhan ( Site 1635)

    RECRUITING

    Wuhan, Hubei, 430014, China

  • The Christie NHS Foundation Trust ( Site 1436)

    RECRUITING

    Manchester, m20 4bx, United Kingdom

  • The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 1639)

    RECRUITING

    Fuzhou, Fujian, 350005, China

  • The First Affiliated Hospital of Wenzhou Medical University ( Site 1604)

    RECRUITING

    Wenzhou, Zhejiang, 325015, China

  • The First Affiliated Hospital of Xi'an Jiaotong University-Oncology department ( Site 1618)

    RECRUITING

    Xi'an, Shaanxi, 710061, China

  • The First Hospital of Jiaxing-urology ( Site 1605)

    RECRUITING

    Jiaxing, Zhejiang, 314001, China

  • The Jikei University Hospital ( Site 0731)

    RECRUITING

    Minato, Tokyo, 105-8471, Japan

  • The Ottawa Hospital - General Campus ( Site 0286)

    RECRUITING

    Ottawa, Ontario, K1H 8L6, Canada

  • The Royal Cornwall Hospital ( Site 1430)

    RECRUITING

    Truro, England, TR1 3LJ, United Kingdom

  • The Second Affiliated Hospital of Xi'an Jiaotong University-Oncology Department ( Site 1619)

    RECRUITING

    Xi'an, Shaanxi, 710004, China

  • The Second Hospital Of Anhui Medical University ( Site 1633)

    RECRUITING

    Hefei, Anhui, 230000, China

  • The Second Hospital of Tianjin Medical University ( Site 1616)

    RECRUITING

    Tianjin, Tianjin Municipality, 300211, China

  • The University of Arizona Cancer Center - North Campus ( Site 0073)

    RECRUITING

    Tucson, Arizona, 85719, United States

  • The University of Osaka Hospital ( Site 0738)

    RECRUITING

    Suita, Osaka, 565-0871, Japan

  • The West Clinic, PLLC dba West Cancer Center ( Site 0063)

    RECRUITING

    Germantown, Tennessee, 38138, United States

  • The first affiliated hospital of Guangzhou medical university ( Site 1637)

    RECRUITING

    Guangzhou, Guangdong, 510000, China

  • Toho University Sakura Medical Center ( Site 0730)

    RECRUITING

    Sakura, Chiba, 285-8741, Japan

  • Tongji Hospital Tongji Medical,Science & Technology ( Site 1632)

    RECRUITING

    Wuhan, Hubei, 430000, China

  • Torbay Hospital ( Site 1429)

    RECRUITING

    Torquay, Devon, TQ2 7AA, United Kingdom

  • Trillium Health Partners - Credit Valley Hospital ( Site 0289)

    RECRUITING

    Mississauga, Ontario, L5M 2N1, Canada

  • UCHealth Highlands Ranch Hospital ( Site 0111)

    RECRUITING

    Highlands Ranch, Colorado, 80129, United States

  • UCLA Hematology/Oncology - Santa Monica ( Site 0044)

    RECRUITING

    Los Angeles, California, 90404, United States

  • UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 0553)

    COMPLETED

    Pátrai, Achaia, 26504, Greece

  • UROEXAM ( Site 1479)

    RECRUITING

    Nitra, Nitra Region, 949 01, Slovakia

  • Unidade Local de Saude Gaia/Espinho - Hospital Eduardo Santos Silva ( Site 1156)

    RECRUITING

    Vila Nova de Gaia, Porto District, 4434-502, Portugal

  • Unidade Local de Saude de Braga - Hospital de Braga ( Site 1151)

    RECRUITING

    Braga, 4710-243, Portugal

  • Unidade Local de Saude de Santa Maria - Hospital de Santa Maria ( Site 1153)

    RECRUITING

    Lisbon, 1649-035, Portugal

  • Unidade Local de Saude de Santo António - Hospital Santo António ( Site 1152)

    RECRUITING

    Porto, 4099-001, Portugal

  • Universidade Federal do Triangulo Mineiro - Hospital de Clinicas ( Site 0262)

    RECRUITING

    Uberaba, Minas Gerais, 38025-350, Brazil

  • Universitaetsklinikum Carl Gustav Carus Dresden-Klinik und Poliklinik für Urologie ( Site 0528)

    COMPLETED

    Dresden, Saxony, 01307, Germany

  • Universitaetsklinikum Freiburg-Klinik für Urologie ( Site 0506)

    RECRUITING

    Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany

  • Universitaetsklinikum Heidelberg ( Site 0531)

    RECRUITING

    Heidelberg, Baden-Wurttemberg, 69120, Germany

  • Universitaetsklinikum Koeln ( Site 0518)

    COMPLETED

    Cologne, North Rhine-Westphalia, 50937, Germany

  • University College London Hospital ( Site 1437)

    RECRUITING

    London, London, City of, NW1 2PG, United Kingdom

  • University Hospitals Cleveland Medical Center ( Site 0043)

    RECRUITING

    Cleveland, Ohio, 44106, United States

  • University Malaya Medical Centre ( Site 0902)

    RECRUITING

    Lembah Pantai, Kuala Lumpur, 59100, Malaysia

  • University of California Davis (UC Davis) Comprehensive Cancer Center ( Site 0114)

    RECRUITING

    Sacramento, California, 95817, United States

  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040)

    RECRUITING

    Orange, California, 92868, United States

  • University of Colorado Anschutz Medical Campus ( Site 0046)

    RECRUITING

    Aurora, Colorado, 80045, United States

  • University of Colorado Health - Lone Tree Medical Center ( Site 0112)

    RECRUITING

    Lone Tree, Colorado, 80124, United States

  • University of Fukui Hospital ( Site 0735)

    RECRUITING

    Eiheiji-cho,Yoshida-gun, Fukui, 910-1193, Japan

  • University of Kentucky Chandler Medical Center ( Site 0048)

    ACTIVE_NOT_RECRUITING

    Lexington, Kentucky, 40536, United States

  • University of Miyazaki Hospital ( Site 0751)

    RECRUITING

    Miyazaki, 889-1692, Japan

  • University of Virginia Health System ( Site 0054)

    RECRUITING

    Charlottesville, Virginia, 22908, United States

  • Universitätsklinikum Marburg-Comprehensive Cancer Center ( Site 0510)

    COMPLETED

    Marburg, Hesse, 35043, Germany

  • Universitätsmedizin Göttingen - Georg-August-Universität-Klinik für Urologie ( Site 0527)

    RECRUITING

    Göttingen, Lower Saxony, 37075, Germany

  • Urologicum Duisburg ( Site 0538)

    RECRUITING

    Duisburg, North Rhine-Westphalia, 47169, Germany

  • Urology of Indiana - Carmel ( Site 0055)

    RECRUITING

    Carmel, Indiana, 46032, United States

  • VCU Health Adult Outpatient Pavillion ( Site 0061)

    RECRUITING

    Richmond, Virginia, 23219, United States

  • Vilnius University Hospital Santaros Clinics Affiliate - National Cancer Center ( Site 1577)

    RECRUITING

    Vilnius, LT-08406, Lithuania

  • Virginia Cancer Specialists (VCS) ( Site 8004)

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Vivantes Klinikum Am Urban ( Site 0512)

    RECRUITING

    Berlin, 10967, Germany

  • Vseobecna fakultni nemocnice v Praze ( Site 0406)

    RECRUITING

    Prague, 12808, Czechia

  • West China Hospital, Sichuan University-Urology Surgery ( Site 1642)

    RECRUITING

    Chengdu, Sichuan, 610041, China

  • Westmead Hospital ( Site 0212)

    RECRUITING

    Westmead, New South Wales, 2145, Australia

  • Wilgers Oncology Centre ( Site 1232)

    RECRUITING

    Pretoria, Gauteng, 0040, South Africa

  • Wits Clinical Research ( Site 1234)

    RECRUITING

    Johannesburg, Gauteng, 2193, South Africa

  • Wuxi People's Hospital ( Site 1612)

    RECRUITING

    Wuxi, Jiangsu, 214023, China

  • Xinjiang Medical University Cancer Hospital - Urumqi-Urology ( Site 1644)

    RECRUITING

    Ürümqi, Xinjiang, 830000, China

  • Yale-New Haven Hospital-Yale Cancer Center ( Site 0064)

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Yantai Yuhuangding Hospital ( Site 1622)

    RECRUITING

    Yantai, Shandong, 264099, China

  • Yokohama City University Medical Center ( Site 0733)

    RECRUITING

    Yokohama, Kanagawa, 232-0024, Japan

  • Yunnan Province Cancer Hospital ( Site 1643)

    RECRUITING

    Kunming, Yunnan, 650107, China

  • Zhejiang Provincial People's Hospital-Urology ( Site 1641)

    RECRUITING

    Hangzhou, Zhejiang, 310014, China

  • klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Site 0521)

    ACTIVE_NOT_RECRUITING

    Munich, Bavaria, 81675, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.